Lv2
190 积分 2024-09-05 加入
Pyroptosis‐Inducing Platinum(IV) Prodrugs via GSDME Pathway for Chemoimmunotherapy and Metastasis Inhibition in Triple‐Negative Breast Cancer
1个月前
已完结
Development of Ciprofibrate Platinum(IV) Nanodrugs as Antimetastatic Agents with COFs as Carriers
1个月前
已完结
Enhancing ovarian cancer treatment with maleimide-modified Pt(IV) prodrug nanoparticles
2个月前
已完结
Discovery of a Novel EF24 Analogue-Conjugated Pt(IV) Complex as Multi-Target Pt(IV) Prodrugs Aims to Enhance Anticancer Activity and Overcome Cisplatin Resistance
2个月前
已完结
Synthesis and anticancer activity of Pt(iv) prodrugs containing 3-bromopyruvic acid as an axial ligand
2个月前
已完结
Red‐Light Photocatalytic Activation Of Pt(IV) Anticancer Prodrugs Using Methylene Blue
2个月前
已完结
Identification of a Photoredox-Active Pt(IV) Complex that Induces Light-Mediated Cell Death
2个月前
已完结
A Highly Stable Photoactivatable Pt(IV) Prodrug with Lower Dark Cytotoxicity for Photochemotherapy
2个月前
已完结
Luminescence-activated Pt(IV) prodrug for in situ triggerable cancer therapy
2个月前
已完结
Pt(IV) Prodrug as a Potential Antitumor Agent with APE1 Inhibitory Activity
2个月前
已完结
皖公网安备34019202002308
